BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23716302)

  • 21. Arylpiperazines with N-acylated amino acids as 5-HT1A receptor ligands.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Pawłowski M; Martinez J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3406-10. PubMed ID: 16677812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enantioconvergent synthesis of (-)-(2R,5S)-1-allyl-2,5-dimethylpiperazine, an intermediate to delta-opioid receptor ligands.
    Janetka JW; Furness MS; Zhang X; Coop A; Folk JE; Mattson MV; Jacobson AE; Rice KC
    J Org Chem; 2003 May; 68(10):3976-80. PubMed ID: 12737580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity.
    Berardi F; Abate C; Ferorelli S; de Robertis AF; Leopoldo M; Colabufo NA; Niso M; Perrone R
    J Med Chem; 2008 Dec; 51(23):7523-31. PubMed ID: 19053780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.
    Qian W; Chen JJ; Human J; Aya T; Zhu J; Biswas K; Peterkin T; Hungate RW; Arik L; Johnson E; Kumar G; Joseph S; Jona J; Guo HX; Wu Z
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1061-7. PubMed ID: 22197141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor.
    Nozawa D; Okubo T; Ishii T; Kakinuma H; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2007 Mar; 15(5):1989-2005. PubMed ID: 17234422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel piperazines: potent melanocortin-4 receptor antagonists with anxiolytic-like activity.
    Nozawa D; Okubo T; Ishii T; Takamori K; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2007 Mar; 15(6):2375-85. PubMed ID: 17267226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y₂ receptor.
    Swanson DM; Wong VD; Jablonowski JA; Shah C; Rudolph DA; Dvorak CA; Seierstad M; Dvorak LK; Morton K; Nepomuceno D; Atack JR; Bonaventure P; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5552-6. PubMed ID: 21802951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
    Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
    Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective synthesis of polysubstituted piperazines and oxopiperazines. Useful building blocks in medicinal chemistry.
    Mordini A; Reginato G; Calamante M; Zani L
    Curr Top Med Chem; 2014; 14(10):1308-16. PubMed ID: 24758427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into homopiperazine-based 5-HT1A/5-HT7R ligands: synthesis and biological evaluation.
    Badarau E; Putey A; Suzenet F; Joseph B; Bojarski A; Finaru A; Guillaumet G
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):301-5. PubMed ID: 19874209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; White NS; Arellano M; Fleck BA; Marinkovic D; Tucci FC; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5237-40. PubMed ID: 16183282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
    Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
    J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand.
    Matulenko MA; Surber B; Fan L; Kolasa T; Nakane M; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5095-8. PubMed ID: 15380206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diastereoselective synthesis of 2-phenyl-3-(trifluoromethyl)piperazines as building blocks for drug discovery.
    Sánchez-Roselló M; Delgado O; Mateu N; Trabanco AA; Van Gool M; Fustero S
    J Org Chem; 2014 Jun; 79(12):5887-94. PubMed ID: 24856203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes.
    Ghoneim OM; Legere JA; Golbraikh A; Tropsha A; Booth RG
    Bioorg Med Chem; 2006 Oct; 14(19):6640-58. PubMed ID: 16782354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
    Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
    Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors.
    Thiele S; Malmgaard-Clausen M; Engel-Andreasen J; Steen A; Rummel PC; Nielsen MC; Gloriam DE; Frimurer TM; Ulven T; Rosenkilde MM
    J Med Chem; 2012 Sep; 55(18):8164-77. PubMed ID: 22957890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.